Hormone replacement therapy post Women's Health Initiative study: where do we stand?
OBJECTIVE
The aim of this review is to look at all publications from the past 18 months, which deal with the impact of the Women's Health Initiative Trial on hormone replacement therapy.


RESULTS
There is a definite decline in the use of hormone replacement therapy among menopausal women.


CONCLUSIONS
More research needs to be done on the long-term effects of hormone replacement therapy, especially with regard to ultra-low dose hormone therapy.
Calleja-Agius
Jean
J
Department of Obstetrics and Gynaecology, Mater Dei Hospital, Msida, Malta. jean@waldonet.net.mt
Brincat
Mark P
MP
D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology / Q000209:etiology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology; D002986:Clinical Trials as Topic; D016889:Endometrial Neoplasms / Q000453:epidemiology / Q000209:etiology; D004967:Estrogens / Q000378:metabolism; D005260:Female; D020249:Hormone Replacement Therapy / Q000706:statistics & numerical data*; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013997:Time Factors
D004967:Estrogens